共 22 条
[1]
Management of Sleep Disorders in Children With Neurodevelopmental Disorders: A Review
[J].
PHARMACOTHERAPY,
2016, 36 (01)
:84-98
[4]
Neuroscience-driven discovery and development of sleep therapeutics.[J].M. Dresler;V.I. Spoormaker;P. Beitinger;M. Czisch;M. Kimura;A. Steiger;F. Holsboer.Pharmacology and Therapeutics.2013,
[5]
Preclinical evaluation of the abuse potential of P itolisant; a histamine H <sub>3</sub> receptor inverse agonist/antagonist compared with M odafinil.[J].M Uguen;D Perrin;S Belliard;X Ligneau;PM Beardsley;JM Lecomte;JC Schwartz.Br J Pharmacol.2013, 3
[6]
[7]
Abnormal amygdala connectivity in patients with primary insomnia: Evidence from resting state fMRI.[J].Zhaoyang Huang;Peipeng Liang;Xiuqin Jia;Shuqin Zhan;Ning Li;Yan Ding;Jie Lu;Yuping Wang;Kuncheng Li.European Journal of Radiology.2011, 6
[8]
Sleep America: Managing the crisis of adult chronic insomnia and associated conditions.[J].Stefanie S. Kraus;Laura A. Rabin.Journal of Affective Disorders.2011, 3
[9]
Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy; safety; and withdrawal.[J].Nava Zisapel;Nir;Moshe Laudon;Doron Garfinkel;Lemoine.Therapeutics and Clinical Risk Management.2011, defa
[10]
The glucocorticoid receptor: Pivot of depression and of antidepressant treatment?.[J].Christoph Anacker;Patricia A. Zunszain;Livia A. Carvalho;Carmine M. Pariante.Psychoneuroendocrinology.2010, 3

